chrisvoncsefalvay/vaers-outcomes huggingface dataset:
the next morning (4/9/21) i had a very bad headache and my lower bad hurt so bad i could barely move, extremely tired. slept most of the day. this continued until Monday. Monday my back was better and headache was better but very tired. Starting Monday night and continuing currently my chest has a sharp pain and i lose my breathe very quickly doing any kind of strenuous activity. Headache and fatigue have continued since then also.
1. Chills, raised temperature and headaches - duration for about six hours then subsided.  Headache continued to next day.  2. Site of injection became warm for about 24 hours.  It was scary.
Fever, chills, headache, sleeplessness Noticed symtoms the morning following vaccine and they subsided around 36-48 hours after
got her first dose of the Pfizer BioNTech Covid-19 vaccine yesterday (14 JUL 2021); not feeling well; pain; headache; joint pain; hard to go to sleep; This is a spontaneous report from a contactable consumer (patient) received from a Pfizer sponsored program. A 32-year-old female pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 14Jul2021 (at the age of 32-year-old) as a dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that, the patient was pregnant at time of vaccination. The gestation period was 8 months. The patient first dose of the Pfizer BioNTech COVID-19 vaccine yesterday (on 14Jul2021) and was not feeling well. She experienced pain, headaches and joint pain. Stated that, her last menstrual period was a year ago. She was 8 months pregnant (35-36 weeks) and her due date was on next month. The patient wanted to know what she can take for pain, specifically headaches and joint pain. The agent provided her the phone number for medical information and has been referred to healthcare professional. Stated that, she tried calling and has not heard back. Stated that, she has not heard from her OBGYN and has been calling them since that morning for that pain. She has had that pain since last night. She just wanted the pain to stop. Stated that, she got her vaccine at 0900-1000. That night, she was cooking and not feeling well and was sore. After that, she stated it was hard to go to sleep, got vaccine on her left and she sleeps on that side and her whole body in pain. Stated that, she needed help from her husband, which was unusual for her. The caller declined to proceed with a report at that time. The outcome of the events was unknown.
Rash on stomach and back. I am not totally sure when it started but I noticed it today.    The first 10 hours after the shot I had difficulty breathing when standing or walking, chills, fever and body aches.
Reaction started exactly 8 minutes after I received the injection. It started out with coughing and I felt very phlegmy, then I had itching from the top of my head to the bottom of my toes. Then I started feeling like I could not breathe, I felt like my throat was closing. They checked my BP and my BP had dropped. They gave me everything and epi pen, steroids, Benadryl and they had already put an IV in. I was not able to  leave for about 4 hours. They sent me home with instructions and if I felt my throat closing up they gave me more steroids. They wanted me to stay at the hospital, but I told them no. They said to go to the emergency room. They Dx with the MRNA shot, I was told me to never take another MNRA injection again. They treated me based on the sx. I have since developed neuropathic pain in my fingers and toes that I have never had before, I also have tremors that I never had before, I do not know if it was caused by the vaccine or from having Covid. I had Covid in November of 2022 where I was in the hospital 3 1/2 weeks in the ICU for 4 days.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: Patient was very nervous about getting covid vaccination.  Shortly after patient recieved covid vaccine, he sat in the chair of waiting area.  He got up from chair after a few mins to try to notify someone he was not feeling well and subsequently started to fall to the ground. Rx technician caught his fall and brought him safely to the ground where he laid.  he was unconscious for a 15 seconds and regained consciousness.  911 was called and paramedics subsequently came, bp was ok after
Pain in upper arm; Warm to touch; Pain become severe; Pain in left arm; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Pain in left arm), FEELING HOT (Warm to touch), PAIN (Pain become severe) and PAIN IN EXTREMITY (Pain in upper arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in left arm). On 15-Feb-2021, the patient experienced FEELING HOT (Warm to touch) and PAIN (Pain become severe). On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in upper arm). At the time of the report, PAIN IN EXTREMITY (Pain in left arm), FEELING HOT (Warm to touch), PAIN (Pain become severe) and PAIN IN EXTREMITY (Pain in upper arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow up information was received on 24 Apr 2021, outcome of the events updated from unknown to recovered. Second dose information updated.
pt recv vax 12MAR97 & pt exp sore throat, vomiting, nausea, chills, warm to touch & a non-productive cough;
stroke; Information has been received from a lawyer referring to a female patient of unknown age. Information about concurrent condition, history condition and concomitant medication was not reported. On an unknown date, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving defendants' zoster vaccine live (ZOSTAVAX) vaccine, the patient suffered a stroke. As a result of these symptoms, the patient was seen and treated by medical providers and was still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms had resulted in physical limitations not presented prior to using the vaccine. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event of stroke was considered to be not recovered and causal relationship was assessed as related.   The lawyer considered the event of stroke to be disability. Upon internal review, the event of stroke was determined to be medically significant.
4 hrs after immunization mother noticed that child left lower anterior thigh was red and swollen. The mother administered MOTRIN. Child c/o itchiness, over the next couple day sx got worse so mother brought child to clinic. Red and indurated area 13 x 9 cm. Told to take BENADRYL, TYLENOL or MOTRIN.
1st dose on 13-May-2022, 2nd not received; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 13th May 2022 via intramuscular route).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional Information: GSK Receipt Date: 17-FEB-2023 Reporter's comment: The reporter stated that at the reporting pharmacy the patient had not yet to receive second dose. The pharmacist was not able to access, at the time of the inbound call, the lot number of the Shingrix administered.  The vaccine administration facility for 1st dose was the same as primary reporter.  The reporter had consented to follow-up. Additional supportive information: Till the time of reporting, the patient did not receive the second dose of vaccine, which had led to incomplete course of vaccination. The details were reported for 1st dose.
Headache, UrticariaPruritus, NauseaVomiting, fatigue and left eye lid swselling Narrative:
Patient resting in car.....she was not making eye contact and short with answers to questions.  Patient was unresponsive, breathing and head movement with eye abnormal movement, attempted to wake patient but unable to , remained unresponsive but breathing. EMS called10:55 Patient continued to be unresponsive SPO2 98+, HR 78 patient pale and diaphoretic.  10:56 Patient was unresponsive ammonia activated and attempted X3 patient continues to be noncoherent and nonverbal. 10:57 Patient with altered mental status and began vomiting, pt aware of name and location.  11:01 B/P 105/76 vomiting continuing with continued altered mental status 11:03 Vomiting and incoherent 11:06 Ems arrived and patient was transported to the local hospital.  Patient awake and state she had a bowel movement on self.  Assisted patient to Cot for EMS.
Patient called on 7/7 and let us know that she had been treated in the ER for HR >100, on and off fever, dizziness, shortness of breath when lying down, fatigue, and neck pain since receiving her second dose of the vaccine. She is following up with a cardiologist and will let us know of the outcome of this appointment.
Inadvertantly received a Pfizer bivalent peds 5-11 instead of a monovalent ped 5-11
fever 102-Wednesday 14JAN97;Thursday noc vomit x 1 days 15JAN97;diarrhea x 1 days 15JAN97;APAP/pedialite given-seen by ER MD;
Immediate pain upon injection. Starting about 36 hours after injection until today (12 days later) thumb area pain constantly.
pt recv vax 19NOV96 & 1DEC96 pt exp pain @ inj site;
Information has been received from a physical therapist concerning an unspecified number of patients, who on unspecified dates, were vaccinated with an unspecified dose of GARDASIL. The physical therapist stated the nurse from the department of health told him that irregular menstrual periods are commonly seen in patients who have received GARDASIL at the clinic.
flu; Initial information was received on 10-Oct-2020 regarding an unsolicited valid non-serious social media case from the patient via social media.  This case is linked to 2020SA294157 (same reporter).  This case involves an unknown demographic patient who got the flu (influenza) after the patient received the flu shot [INFLUENZA VACCINE].  Medical history, concomitant medication, past medical treatment, vaccination and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, batch number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, (latency unknown) the patient got the flu (influenza) (non serious) following administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  The event outcome was unknown for the event, at the time of reporting.  There will be no information available on the batch number for this case.
cataract; This is a spontaneous report from a non-contactable consumer (patient's daughter) via medical information team. An 84-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 18Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient received the first dose of the COVID vaccine on 18Jan2021 and was scheduled for 08Feb2020 for the second dose. In between that she needed to have cataract surgery, if she can't make it to the second dose. The consumer wanted to know what would happen if she received the second dose outside of the 21 days and she wanted to know what was the timing of the second dose of PFIZER-BIONTECH COVID-19 VACCINE and can it be received earlier or later than 3 weeks. The event was considered non-serious by the reporter. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Two weeks following immunizations with flu vaccine developed cough, coryza, weakness over the course of week developed dysarthia, dysphagia with cranial nerve paresis on exam. Diagnosed with ALS. According to 213289, 60 day follow up, patient died 03/20/2002 from ALS, unassociated with flu vaccine.  Follow up on 09/18/2001: "The patients right arm was prepped and draped in a sterile fashion.  1% Xylocaine was employed for local anesthesia.  A hand injection of contrast through a peripheral angiocath provided opacification of the deep veins of the right arm.  The right basilic vein was accessed under fluoroscopic guidance with a micropuncture set.  A cook PICC catheter was then trimmed to a length of 36cm and advanced through a peel-away sheath into the SVC.  A hand injection of contrast through the catheter reveals the tip in the superior vena cava. The catheter was flushed and sutured in place.  The catheter was then heparinized with 400 units Heparin and the patient was returned to the post-operative lounge in stable condition. "
sinus infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 24Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: SINUSITIS (non-serious) with onset Mar2021, outcome "unknown", described as "sinus infection".  Additional information:  The patient had the first dose of the Pfizer Covid-19 Vaccine on 24Feb2021. She is scheduled to have the second dose today (at the time of the reporting), but she had a sinus infection since the day before yesterday, 14Mar2021. She would like to know how long it would take before she feels better and how long to wait before taking the second dose of the vaccine.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
around 2:45pm, patient received flucelvax. pt was standing and waiting for proof of vaccine and started complaining of lighthead. Pt sit down on a chair and 2-3 mins later, pt fainted and hit head on the ground. 2 other people helped him sit back on a chair. patient was conscious, able to talk and laugh. called 911 and while waiting, I got his blood pressure and temperature. Pt had low blood pressure 80/60. Had to checked blood pressure twice. temperature was 35.5 celcius. gave him cold bottle of water. 911 arrived and checked him and his Vital signs. Everything was okay. Patient stayed in pharmacy 20 more mins and said feeling ok to drive back home. called 4 pm to follow up. he was okay.
My symptoms of a bad cold and scratchy throat. My ears were plugged and I started having throat drainage. I started taking Tylenol and Sudafed for my head congestion until I did go get tested for COVID-19. After I tested positive, I received the COVID 19 Antiviral Paxlovid which made a huge difference. Within 2 days I was feeling better other than the fatigue. I am still having slight fatigue but it is getting better.
Warm sensation (numbness) in left thigh. Spread to spine and mid chest and all the way down to the left toe, groin and left butt cheek. Burning and numbness down entire left leg, ongoing. Left toe  swollen and red, nail turned black, fell off. Wasn't an infection and it wasn't gout.  Also had vertigo for 4 or 5 days starting around the 5th along with the numbness.
pt recv vax 10MAY95 & 15MAY95 devel 1 spot on body; 17MAY was completely covered w/chicken pox; No further details were provided;
This spontaneous report was received from a healthcare professional regarding a patient of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date in October 2015, the patient was vaccinated with GARDASIL dose 1 and on April 2016 with Dose 2 (inappropriate schedule of drug administration). No concomitant medication was reported. The outcome of the event was unknown. No PQC (product quality complaint was involved). Additional information has been requested.
There were no adverse events to this 10 year 7 month old who recieved the 12 year old dose of vaccine.
Starting in the beginning of December 2022, he continued to get sick and was getting so bad that I took him to the local clinic and they did a bunch of tests to rule out RSV, COVID-19 and the flu but all were negative. When they did his oxygen level it was in the 70s so they rushed him to a local hospital. He was admitted into the hospital in the ICU where he was being treated for heart failure (which he didn't have). After some intervention from our son who is a doctor, he was accurately treated for pneumonia and septic shock. He was kept in the hospital for 9 days. He was discharged 9 days prior to the December holiday. As of now, he is still very lethargic and sleeping all day.
Immunizations given 8/7/13. Child had seizure with temperature of 104 on 8/14/13. Follow up in office 8/16/13 - Febrile convulsion viral infections.
Started with numbness and tingling in feet and hands.  1/22/2010 progressed to face - diagnosed with Bells palsy.  1/31/2010 admitted to  hospital as I could no longer stand without falling or walk on my own.
Left upper arm swollen, red, warm, painful within six hours, lasting four days with lingering soreness to touch. Warm soaks, Advil only treatment.
VACCINE WAS ADMINISTERED PAST 6 HOURS FROM VIAL PUNCTURE; This spontaneous report received from a pharmacist concerned a 31 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known drug allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: 23-JUN-2021) dose was not reported, administered on 28-APR-2021 13:57 for prophylactic vaccination. No concomitant medications were reported.  On 28-APR-2021, the subject experienced vaccine was administered past 6 hours from puncture. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of vaccine was administered past 6 hours from puncture was not reported. This report was non-serious. This case, from the same reporter is linked to.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. No information on concurrent conditions and medical history were not reported. On 14-JUL-2015 and 15-JUL-2015, the patients were vaccinated with improperly stored GARDASIL 9 (unknown strength, dose and route) Lot # K026246, with expiry date of 28-JAN-2017 and lot # L006547 with expiry date of 04-MAR-2017. Concomitant medications were not reported. No adverse effects were reported. The outcome of incorrect product storage was unknown. There was no product quality complaint involved. This is one of the three reports received from the same reporter. Additional information has been requested.
10 x 12 cm erythema patch with central induration on right leg, no blisters.
Patient is a 40 year old who presents requesting vaccination for COVID-19. Patient's identity was verified utilizing two patient identifiers. Allergies reviewed and patient has no history of severe allergic reactions.    The patient or surrogate received COVID-19 vaccine fact sheet and was given opportunity to ask questions.  See Immunizations activity for vaccine details.  Patient agrees to remain for observation period to monitor.    Noted a possible malfunction on the vanish point syringe. Noted the spring at the hub of the syringe. Noted some content of the syringe leaked out on to the patient arm and arm rest of chair after needle retracted. Upon inspection of the syringe there was a spring in the hub of the syringe. And there was vaccine content in the barrel. It is unclear on the exact amount of the vaccine the patient received. RN was notified immediately, she took a picture of the syringe. Immunization coordination was notified as well. By guidelines patient was advised to revaccinate immediately how ever patient declined.
Chills, Sweating, heart racing throughout the night. Extreme body aches and extreme tiredness which lasted 3 days or more. Body aches, tiredness, brain fog have lasted up to now intermittently. Also strange smells in my nose intermittently and off and on cough. Just don't feel well overall
localized swelling, redness within hours of administration not directly at the site given but on inner thigh
COVID positive Narrative:  Patient tested positive for COVID on 4/6/21 in the urgent room. He was admitted for treatment with remdesivir and dexamethasone due to low pulse oxygen. Patient reported difficulty with gait/balance and dysuria upon admission.
Soreness around vaccination site; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP6955), via an unspecified route of administration in left arm on 16Mar2021 at 09:15 (at the age of 59-years-old) as a single dose for COVID-19 Immunisation. Medical history included allergy (unspecified allergies to medications, food, or other products). The patient was receiving unspecified concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. On 16Mar2021 at 16:00, the patient experienced soreness around vaccination site. The patient did not receive treatment for the event. The clinical outcome for the event soreness around vaccination site was not recovered.   No follow-up attempts are needed. No further information is expected.